| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 06/21/2011 | US7964724 Chiral cis-imidazolines |
| 06/21/2011 | US7964628 Fibrinogen receptor antagonists and their use |
| 06/21/2011 | US7964620 Imidazole derivatives |
| 06/21/2011 | US7964618 2-[(3R)-1-[5-(cyclohexylcarbamoyl)-6-propylsulfanyl-pyridin-2-yl]-3-piperidyl]acetic acid, for example; compounds possess human 11- beta-hydroxysteroid dehydrogenase type1 enzyme (11 beta HSD1) inhibitory activity and accordingly have value in treatment of disease states including metabolic syndrome |
| 06/21/2011 | US7964602 Biaryl compounds useful as agonists of the Gpr38 receptor |
| 06/21/2011 | US7964597 Piperazinyl-sulfonamide derivatives useful in the treatment of GPR38 receptor mediated diseases |
| 06/21/2011 | US7964593 Indolone-acetamide derivatives, processes for preparing them and their uses |
| 06/21/2011 | US7964592 2,4-di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 06/21/2011 | US7964531 3-phenoxy-4-pyridazinol derivatives and herbicidal composition containing the same |
| 06/21/2011 | CA2632283C Polymorphs of a c-met/hgfr inhibitor |
| 06/21/2011 | CA2507707C 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors |
| 06/21/2011 | CA2495386C Protein kinase inhibitors and uses thereof |
| 06/21/2011 | CA2483303C Cinnamic acid amides |
| 06/21/2011 | CA2474192C Nicotinamide derivates useful as p38 inhibitors |
| 06/21/2011 | CA2473468C Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 06/21/2011 | CA2442114C N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor |
| 06/21/2011 | CA2359115C Acyl derivatives which treat vla-4 related disorders |
| 06/16/2011 | WO2011072241A1 4 -oxo- ih -quinoline- 3 - carboxamides as modulators of atp -binding cassette transporters |
| 06/16/2011 | WO2011071996A1 Faah inhibitors |
| 06/16/2011 | WO2011071849A2 Pyridinone hydroxycyclopentyl carboxamides: hiv integrase inhibitors with therapeutic applications |
| 06/16/2011 | WO2011071314A2 Processes for preparing crystalline forms a and b of ilaprazole and process for converting the crystalline forms |
| 06/16/2011 | WO2011071255A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 06/16/2011 | WO2011071136A1 Therapeutic agent for fibromyalgia |
| 06/16/2011 | WO2011071095A1 Benzamide compound |
| 06/16/2011 | WO2011070588A1 Process for the preparation of imatinib and salts thereof |
| 06/16/2011 | WO2011070152A2 Novel antiviral compounds, which are aryl 3-deazauridine analogues at c3 position |
| 06/16/2011 | WO2011070131A1 5-amino- 4-hydroxypentoyl amides |
| 06/16/2011 | WO2011070039A1 Spiro indole - cyclopropane indolinones useful as ampk modulators |
| 06/16/2011 | WO2011070025A1 Compounds based on a triazole group that are capable of complexing at least one metallic element and coordination complex based on these compounds |
| 06/16/2011 | WO2011069952A1 Novel cationic 4-aminoindoles, dye composition comprising a cationic 4-aminoindole, processes therefor and uses thereof |
| 06/16/2011 | WO2011069951A1 Imidazolidinedione derivatives |
| 06/16/2011 | WO2011069898A1 Novel cationic aminopyridines, dye composition comprising a cationic aminopyridine, processes therefor and uses thereof |
| 06/16/2011 | WO2011069761A1 Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereof |
| 06/16/2011 | WO2011069608A1 S-lenalidomide, polymorphic forms thereof and blend comprising s- und r-lenalidomide |
| 06/16/2011 | WO2011022509A3 Substituted benzoazepines as toll-like receptor modulators |
| 06/16/2011 | WO2011021726A3 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation |
| 06/16/2011 | WO2010100476A3 Improved process |
| 06/16/2011 | US20110144332 Pyrazole compounds that modulate hsp90 activity |
| 06/16/2011 | US20110144331 Cinnoline Compounds for the Treatment of Anxiety, Cognitive and Mood Disorders |
| 06/16/2011 | US20110144330 2,4-Pyrimidinediamine Compounds and their Uses |
| 06/16/2011 | US20110144162 Oxotetrahydrofuran-2-yl-benzimidazole derivative |
| 06/16/2011 | US20110144161 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors |
| 06/16/2011 | US20110144159 Ether benzylidene piperidine aryl carboxamide compounds useful as faah inhibitors |
| 06/16/2011 | US20110144158 Isoindole-imide compounds and compositions comprising and methods of using the same |
| 06/16/2011 | US20110144157 Pyrrole derivatives, preparation of same and therapeutic application thereof |
| 06/16/2011 | US20110144153 Amide compound |
| 06/16/2011 | US20110144150 Bridged bicyclic rho kinase inhibitor compounds, composition and use |
| 06/16/2011 | US20110144148 Acetylcholinesterase dual inhibitors |
| 06/16/2011 | US20110144140 Pyridinyl-pyrimidine derivatives useful as potassium channel modulating agents |
| 06/16/2011 | US20110144133 Substituted pyrimidone derivatives |
| 06/16/2011 | US20110144122 Derivatives of 2-oxoalkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same |
| 06/16/2011 | US20110144121 Bicyclic pyrazolo-heterocycles |
| 06/16/2011 | US20110144120 Phenyl-alkyl piperazines having tnf-modulating activity, preparation method, and therapeutic use thereof |
| 06/16/2011 | US20110144118 Antiviral salts |
| 06/16/2011 | US20110144114 Substituted triazinone derivatives |
| 06/16/2011 | US20110144110 Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents |
| 06/16/2011 | US20110144108 Substituted piperidine compounds and methods of their use |
| 06/16/2011 | US20110144107 Compounds and compositions useful for the treatment of malaria |
| 06/16/2011 | US20110144106 Novel cyclopropane indolinone derivatives |
| 06/16/2011 | US20110144101 Macrocyclic compounds useful as pharmaceuticals |
| 06/16/2011 | US20110144094 Heterocyclic tetracyclic tetrahydrofuran derivatives |
| 06/16/2011 | US20110144090 Compounds and methods of use thereof |
| 06/16/2011 | US20110144084 6 substituted 2- heterocyclylamino pyrazine compounds as chk-1 inhibitors |
| 06/16/2011 | US20110144081 Pyrrolidine derivatives |
| 06/16/2011 | US20110144080 Pyrazole derivatives as protein kinase modulators |
| 06/16/2011 | US20110144075 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 06/16/2011 | US20110144070 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 06/16/2011 | US20110144068 3,4-diarylpyrazoles as protein kinase inhibitors |
| 06/16/2011 | US20110144067 N-Acyloxysulfonamide and N-Hydroxy-N-Acylsulfonamide Derivatives |
| 06/16/2011 | US20110144060 Substituted pyrazinone melanin concentrating hormone receptor-1 antagonists and methods |
| 06/16/2011 | US20110144056 Pyrazole derivatives useful as inhibitors of faah |
| 06/16/2011 | US20110143942 Pyrazolyl-Substituted Heterocycles and Their Use as Phytosanitary Products |
| 06/16/2011 | US20110143939 Quinoxalin-2-one derivatives, compositions which protect useful plants and comprise these derivatives, and processes for their preparation and their use |
| 06/16/2011 | US20110143141 Photochromic compounds and compositions |
| 06/16/2011 | US20110142856 Compound containing basic group and use thereof |
| 06/16/2011 | US20110142798 Hepatitis c virus inhibitors |
| 06/16/2011 | US20110140092 Charge transport compositions and electronic devices made with such compositions |
| 06/16/2011 | US20110140056 Indeno-fused ring compounds |
| 06/16/2011 | US20110140044 Organosulfur compound, process for producing the same, and organic electroluminescence element using the same |
| 06/16/2011 | CA2783929A1 5-amino-4-hydroxypentoyl amides |
| 06/16/2011 | CA2783540A1 Pyridinone hydroxycyclopentyl carboxamides: hiv integrase inhibitors with therapeutic applications |
| 06/16/2011 | CA2783537A1 Benzamide compound |
| 06/16/2011 | CA2783314A1 4-oxo-1h-quinoline-3-carboxamides as modulators of atp-binding cassette transporters |
| 06/16/2011 | CA2781839A1 Spiro indole - cyclopropane indolinones useful as ampk modulators |
| 06/16/2011 | CA2781685A1 Imidazolidinedione derivatives |
| 06/16/2011 | CA2777907A1 Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereof |
| 06/15/2011 | EP2332963A2 Process for preparing macrocyclic compounds |
| 06/15/2011 | EP2332933A1 Epithelial sodium channel (ENaC) inhibitors |
| 06/15/2011 | EP2332932A1 Novel crystal forms of 4-(2-aminopyridin-4-yl)-3-(4 fluoro- phenyl)-1-(1,4,5,6-tetrahydro-6-oxopyridazin-3-yl)-1h-pyra-zole methanesulfonate and process for production of same |
| 06/15/2011 | EP2332924A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
| 06/15/2011 | EP2332923A1 5-ý2-(methylthio)ethoxy¨pyrimidine-2-amine manufacturing method |
| 06/15/2011 | EP2332922A1 N-substituted azoles and their use as MEK-1 and/or ERK-2 modulators |
| 06/15/2011 | EP2332918A1 Sulfonamide derivatives of polycyclic dyes for analytical applications |
| 06/15/2011 | EP2332912A1 Heteroarylaminosulfonylphenylderivates for use as sodium or calcium channel blockers in the treatment of pain |
| 06/15/2011 | EP2332909A1 Hydroxybenzamide derivatives and their use as inhibitors of HSP90 |
| 06/15/2011 | EP2332905A1 BCRP/ABCG3 Inhibitor |
| 06/15/2011 | EP2331530A2 Fused multicyclic compounds as protein kinase inhibitors |
| 06/15/2011 | EP2331526A2 Pyrimidine derivatives as kinase inhibitors |
| 06/15/2011 | EP2331525A2 Halofuginone analogs for inhibition of trna synthetases and uses thereof |
| 06/15/2011 | EP2331524A1 Heterocyclically substituted anilinopyrimidines as fungicides |